Stockscreener 앱 받기
1.745
29.64%
-0.735
시간 외 거래:
1.77
0.025
+1.43%
Humacyte Inc 주식(HUMA)의 최신 뉴스
Humacyte Missed Revenue Forecasts But Expanded Symvess Access - Finimize
Humacyte stock price target lowered to $7 at BTIG on mixed Q2 results - Investing.com Canada
Humacyte's 2025 Q2 Earnings Call: Unpacking Key Contradictions on Sales, CMS Impact, and FDA Interactions - AInvest
Sitryx gets back rights to drug from Lilly deal; Humacyte is cutting costs - Endpoints News
Humacyte Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Humacyte Q2 2025 misses EPS and revenue targets - Investing.com UK
Transcript : Humacyte, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
Humacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Humacyte Plunges 10.08% on Disappointing Earnings - AInvest
Assessing Humacyte's Long-Term Viability: A Cautionary Tale of Recurring Losses and Revenue Shortfalls - AInvest
Humacyte earnings missed by $0.08, revenue fell short of estimates - Investing.com Canada
Humacyte Posts Q2 Revenue Miss - The Motley Fool
Humacyte misses Q2 revenue estimates, net loss narrows - MarketScreener
Humacyte Q2 Earnings: Military Hospitals Join 277-Strong Network as Product Sales Hit Record High - Stock Titan
Is Humacyte Inc. forming a double bottomBottom Formation Alert - mustnews.co.kr
Humacyte HUMA Q2 2025 Earnings Preview Upside Potential Driven by Product Innovations - AInvest
Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 - The Manila Times
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
What are Humacyte Inc. Equity Warrant company’s key revenue driversMassive stock growth - Jammu Links News
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors - MSN
How does Humacyte Inc. Equity Warrant compare to its industry peersSuperior profit margins - Jammu Links News
Why is Humacyte Inc. stock attracting strong analyst attentionExceptional gains - Jammu Links News
What are Humacyte Inc. company’s key revenue driversAccess powerful market insights for free - Jammu Links News
What makes Humacyte Inc. stock price move sharplyUnlock powerful market trend analysis - Jammu Links News
How does Humacyte Inc. compare to its industry peersUnlock powerful market insights for success - Jammu Links News
What institutional investors are buying Humacyte Inc. stockFree Daily Trading Room Entry - Jammu Links News
Why is Humacyte Inc. Equity Warrant stock attracting strong analyst attentionMaximize gains with timely market signals - Jammu Links News
Should I hold or sell Humacyte Inc. Equity Warrant stock in 2025High-velocity capital appreciation - Jammu Links News
Is Humacyte Inc. a growth stock or a value stockDiscover the next big stock winners - Jammu Links News
Is Humacyte Inc. stock overvalued or undervaluedCapitalize on emerging investment opportunities - Jammu Links News
What are the latest earnings results for Humacyte Inc. Equity WarrantAchieve consistent returns with proven methods - jammulinksnews.com
What drives Humacyte Inc. Equity Warrant stock priceInvest confidently with proven investment plans - Jammu Links News
Should I hold or sell Humacyte Inc. stock in 2025Discover hidden gems in the stock market - Jammu Links News
Does Humacyte Inc. Equity Warrant stock perform well during market downturnsPhenomenal capital appreciation - Jammu Links News
How many analysts rate Humacyte Inc. as a “Buy”Capitalize on momentum-driven stocks - Jammu Links News
Published on: 2025-08-03 10:43:46 - Jammu Links News
How volatile is Humacyte Inc. stock compared to the marketInvest smarter with expert stock recommendations - Jammu Links News
What catalysts could drive Humacyte Inc. Equity Warrant stock higher in 2025Get professional advice for market timing - Jammu Links News
What is Humacyte Inc. Equity Warrant company’s growth strategyRapid return acceleration - Jammu Links News
When is Humacyte Inc. Equity Warrant stock expected to show significant growthHigh-octane financial growth - Jammu Links News
Does Humacyte Inc. stock perform well during market downturnsFree Real-Time Stock Data - Jammu Links News
What are analysts’ price targets for Humacyte Inc. in the next 12 monthsPhenomenal investment performance - Jammu Links News
What is the dividend policy of Humacyte Inc. stockBuild a winning portfolio with smart picks - Jammu Links News
Is Humacyte Inc. Equity Warrant a growth stock or a value stockExceptional market performance - Jammu Links News
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights - MSN
Measuring Humacyte Inc.’s beta against major indicesAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) Shareholders - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. LawsuitHUMA - ACCESS Newswire
Humacyte, Inc. (NASDAQ:HUMA): Is Breakeven Near? - Yahoo Finance
Is Humacyte Inc. Equity Warrant in Accumulation Phase NowWealth Building Stock Market Ideas Based on Momentum - metal.it
What institutional investors are buying Humacyte Inc. Equity Warrant stockStock Market Entry Points To Watch Now - jammulinksnews.com
When is Humacyte Inc. stock expected to show significant growthAchieve rapid capital gains with smart investing - jammulinksnews.com
1.02%
3.70%
자본화:
|
볼륨(24시간):